Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Vaidya, Tanaya
AbbVie Inc
159
:
Pharmacokinetics, Pharmacodynamics & Safety of Budigalimab, An Anti-PD-1 Monoclonal Antibody, in People Living With HIV-1
Tanaya Vaidya
Favorite
van Duijn, Esther
TNO
155
:
The Human Metabolism of Lufotrelvir, a Prodrug for the Treatment of SARS-COV2, Investigated By LC+AMS
Esther van Duijn
Favorite
van Rongen, Anne
Leiden Univ
A005
:
Implications of Being Born Small for Gestational Age on the Exposure of Vancomycin & Gentamicin In Neonates
Anne van Rongen
Favorite
A005
:
Implications of Being Born Small for Gestational Age on the Exposure of Vancomycin & Gentamicin In Neonates
Anne van Rongen
Favorite
Vashi, Vijay
SK Life Science Inc
066
:
Population Pharmacokinetic Analysis of Cenobamate
Vijay Vashi
Favorite
Vatsalya, Vatsalya
University of Louisville
150
:
The Gut-immune-liver Axis in Patients With Alcohol Use Disorder & Clinically Low Serum Zinc Levels
Vatsalya Vatsalya
Favorite
Vernillet, Laurent
BioCryst Pharmaceuticals, Inc.
106
:
First-in-Human Safety, Pharmacokinetics & Pharmacodynamics of the Oral Factor D Inhibitor BCX10013
Laurent Vernillet
Favorite
Vuppugalla, Ragini
Kyowa Kirin Co Ltd
087
:
Development of a Pharmacokinetic-Tumor Target Engagement Model Using Nonclinical Data to Inform Phase 1 Dosing Scheme for a Novel Bispecific CD40-EpCAM Antibody, KK2269
Ragini Vuppugalla
Favorite
